A Multi-Center, Non-Interventional Study on Effectiveness and Treatment Persistence of Guselkumab in Patients with ULcerative Colitis and Crohn’s DiseasE in Real-World Practice in Saudi Arabia (EAGLE)

drug protocol number
CNTO1959IB
drug sponsor
Johnson & Johnson / IQIVIA
drug study
Guselkumab( Tremfya)
drug trial site
Al Salama Hospital (Jeddah)
drug status
Ongoing
drug phase